Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 43% ± 13% | |
lung | 17 studies | 52% ± 16% | |
brain | 13 studies | 33% ± 13% | |
intestine | 11 studies | 54% ± 22% | |
kidney | 9 studies | 56% ± 13% | |
eye | 9 studies | 48% ± 19% | |
bone marrow | 6 studies | 36% ± 15% | |
liver | 6 studies | 50% ± 20% | |
lymph node | 5 studies | 47% ± 22% | |
uterus | 5 studies | 55% ± 20% | |
pancreas | 4 studies | 64% ± 21% | |
placenta | 4 studies | 62% ± 23% | |
prostate | 4 studies | 38% ± 10% | |
breast | 4 studies | 51% ± 9% | |
heart | 3 studies | 36% ± 12% | |
adrenal gland | 3 studies | 50% ± 9% | |
esophagus | 3 studies | 59% ± 26% | |
skin | 3 studies | 40% ± 10% | |
thymus | 3 studies | 67% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4072.40 | 1445 / 1445 | 100% | 73.49 | 183 / 183 |
liver | 100% | 3828.36 | 226 / 226 | 100% | 111.10 | 406 / 406 |
ovary | 100% | 1995.24 | 180 / 180 | 100% | 159.39 | 430 / 430 |
uterus | 100% | 2298.24 | 170 / 170 | 100% | 102.26 | 459 / 459 |
kidney | 100% | 5123.02 | 89 / 89 | 100% | 81.14 | 900 / 901 |
brain | 100% | 3516.91 | 2636 / 2642 | 100% | 94.48 | 705 / 705 |
skin | 100% | 2363.01 | 1804 / 1809 | 100% | 89.12 | 472 / 472 |
prostate | 100% | 2610.22 | 244 / 245 | 100% | 83.09 | 502 / 502 |
adrenal gland | 100% | 4863.13 | 258 / 258 | 100% | 98.18 | 229 / 230 |
thymus | 100% | 2509.66 | 651 / 653 | 100% | 92.60 | 604 / 605 |
breast | 100% | 3275.64 | 459 / 459 | 99% | 91.67 | 1112 / 1118 |
bladder | 100% | 3483.52 | 21 / 21 | 99% | 91.50 | 500 / 504 |
lung | 99% | 2174.93 | 573 / 578 | 100% | 73.71 | 1155 / 1155 |
stomach | 100% | 3349.96 | 359 / 359 | 99% | 94.83 | 283 / 286 |
intestine | 100% | 4327.25 | 966 / 966 | 98% | 91.28 | 518 / 527 |
pancreas | 98% | 1625.91 | 322 / 328 | 100% | 66.66 | 178 / 178 |
adipose | 100% | 3564.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 132.10 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 134.90 | 29 / 29 |
muscle | 100% | 7930.59 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2138.47 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 86.53 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 74.79 | 1 / 1 |
blood vessel | 100% | 3595.88 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 10709.71 | 857 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 41% | 1194.05 | 382 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0021762 | Biological process | substantia nigra development |
GO_0042776 | Biological process | proton motive force-driven mitochondrial ATP synthesis |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0015986 | Biological process | proton motive force-driven ATP synthesis |
GO_0005753 | Cellular component | mitochondrial proton-transporting ATP synthase complex |
GO_0000276 | Cellular component | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0046933 | Molecular function | proton-transporting ATP synthase activity, rotational mechanism |
GO_0005515 | Molecular function | protein binding |
Gene name | ATP5PF |
Protein name | ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6) ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6) (ATP synthase peripheral stalk subunit F6) |
Synonyms | ATP5J ATP5A ATPM hCG_2007844 |
Description | FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements. Also involved in the restoration of oligomycin-sensitive ATPase activity to depleted F1-F0 complexes. FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements. Also involved in the restoration of oligomycin-sensitive ATPase activity to depleted F1-F0 complexes. . FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements. Also involved in the restoration of oligomycin-sensitive ATPase activity to depleted F1-F0 complexes. . FUNCTION: Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(0) domain and the peripheric stalk, which acts as a stator to hold the catalytic alpha(3)beta(3) subcomplex and subunit a/ATP6 static relative to the rotary elements. Also involved in the restoration of oligomycin-sensitive ATPase activity to depleted F1-F0 complexes. . |
Accessions | ENST00000400099.5 P18859 A8MUH2 ENST00000400093.3 [P18859-1] ENST00000457143.6 [P18859-2] ENST00000284971.8 [P18859-1] Q6IB54 Q6NZ59 ENST00000400087.7 [P18859-1] ENST00000400090.7 [P18859-1] ENST00000400094.5 [P18859-1] |